Echelon should be bought on near-term weakness, says Cantor
After Echelon reported slightly better than expected results and announced that its CEO would be stepping down from the position due to lung cancer, Cantor Fitzgerald believes that the interim CEO will be "an outstanding leader." The firm reiterates a Buy recommendation on the stock. :theflyonthewall.com
News For ELON From The Last 14 Days
Check below for free stories on ELON the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
